Trial · NCT01474512
Adverse events4,788
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 4,788
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhoea | Gastrointestinal disorders | Placebo - Induction Period | 4 | 431 | 5 |
| other | Diarrhoea | Gastrointestinal disorders | Ixe Q4W - Induction Period | 10 | 432 | 11 |
| other | Diarrhoea | Gastrointestinal disorders | Ixe Q2W - Induction Period | 9 | 433 | 11 |
| other | Diarrhoea | Gastrointestinal disorders | Ixe/Placebo- Maintenance Period Primary Pop | 8 | 226 | 8 |
| other | Diarrhoea | Gastrointestinal disorders | Ixe/Ixe Q12W - Maintenance Period Primary Pop | 4 | 227 | 4 |
| other | Diarrhoea | Gastrointestinal disorders | Ixe/Ixe Q4W - Maintenance Period Primary Pop | 8 | 229 | 8 |
| other | Diarrhoea | Gastrointestinal disorders | Placebo Resp/Placebo - Maintenance Period Secondary Pop | 0 | 16 | 0 |
| other | Diarrhoea | Gastrointestinal disorders | Placebo Non-Resp/Ixe Q4W - Maintenance Period Secondary Pop | 22 | 391 | 29 |
| other | Diarrhoea | Gastrointestinal disorders | Ixe Q4W Non-Resp/Ixe Q4W - Maintenance Period Secondary Pop | 1 | 78 | 1 |
| other | Diarrhoea | Gastrointestinal disorders | Q2W Non-Resp/Q4W - Maintenance Period Secondary Pop | 2 | 62 | 2 |
| other | Diarrhoea | Gastrointestinal disorders | Ixe Q4W - Maintenance Period Relapse Pop | 8 | 348 | 9 |
| other | Diarrhoea | Gastrointestinal disorders | Placebo Long-Term Extension | 1 | 26 | 1 |
| other | Diarrhoea | Gastrointestinal disorders | Ixe Long-Term Extension | 21 | 1,054 | 24 |
| other | Diarrhoea | Gastrointestinal disorders | Total Ixe Long-Term Extension | 21 | 1,075 | 24 |
| other | Diarrhoea | Gastrointestinal disorders | Placebo Post-Treatment Follow-Up | 0 | 18 | 0 |
| other | Diarrhoea | Gastrointestinal disorders | Ixe Q12W Post-Treatment Follow-Up | 0 | 25 | 0 |
| other | Diarrhoea | Gastrointestinal disorders | Ixe Q4W Post Treatment Follow-Up | 2 | 700 | 2 |
| other | Diarrhoea | Gastrointestinal disorders | Ixe Q2W Post-Treatment Follow-Up | 1 | 285 | 1 |
| other | Pancreatitis | Gastrointestinal disorders | Placebo - Induction Period | 0 | 431 | 0 |
| other | Pancreatitis | Gastrointestinal disorders | Ixe Q4W - Induction Period | 0 | 432 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01474512/events